Axa
ONCE

Axa’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Axa’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-57,236
Closed -$2.24M – 1426
2018
Q4 		$2.24M Buy
57,236
+19,724
+53% +$855K 0.01% 796
2018
Q3 		$2.05M Sell
37,512
-25,403
-40% -$1.74M 0.01% 873
2018
Q2 		$5.21M Sell
62,915
-37,085
-37% -$2.86M 0.02% 643
2018
Q1 		$6.66M Sell
100,000
-1,016
-1% -$58.7K 0.03% 568
2017
Q4 		$5.19M Sell
101,016
-3,512
-3% -$252K 0.02% 641
2017
Q3 		$9.32M Sell
104,528
-19,198
-16% -$1.46M 0.04% 459
2017
Q2 		$7.39M Sell
123,726
-27,919
-18% -$1.56M 0.03% 508
2017
Q1 		$8.09M Sell
151,645
-4,627
-3% -$275K 0.04% 465
2016
Q4 		$7.8M Buy
156,272
+15,913
+11% +$852K 0.04% 468
2016
Q3 		$8.43M Buy
140,359
+81
+0.1% +$4.67K 0.04% 449
2016
Q2 		$7.17M Sell
140,278
-107,510
-43% -$4.59M 0.03% 478
2016
Q1 		$7.31M Buy
247,788
+85,478
+53% +$2.7M 0.03% 465
2015
Q4 		$7.35M Sell
162,310
-3,412
-2% -$179K 0.03% 458
2015
Q3 		$6.92M Buy
165,722
+133,768
+419% +$6.98M 0.03% 476
2015
Q2 		$1.93M Hold
31,954
– – 0.01% 795
2015
Q1 		$2.48M Buy
+31,954
New +$1.84M 0.01% 759

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Axa's ONCE Position: Q1 2019 in Review

Axa sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2019, closing a stake of 57,236 shares — an estimated $2.24M sold.

Axa first reported a position in ONCE in Q1 2015 and held it in 16 quarters. The position peaked at $9.32M in Q3 2017. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.

  • Axa reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Axa sold 57,236 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $2.24M.
  • Axa first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 16 quarters.
  • Axa's Spark Therapeutics, Inc. Common Stock position peaked at $9.32M in Q3 2017.
  • 199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Axa's 13F filing for Q1 2019, filed 14 May 2019.